首页> 美国卫生研究院文献>Infection and Immunity >Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.
【2h】

Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.

机译:免疫球蛋白G2抗体促进放线放线杆菌的嗜中性粒细胞杀伤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sera from patients with localized juvenile periodontitis (LJP) often contain markedly elevated levels of immunoglobulin G2 (IgG2) antibodies reactive to cell envelope constituents of Actinobacillus actinomycetemcomitans. The objective of this study was to determine if these IgG2 antibodies are capable of supporting phagocytosis and killing of A. actinomycetemcomitans by human neutrophils. Polyclonal IgG2 antibodies were prepared from high-titer LJP serum by affinity chromatography, yielding a preparation which was > 99% subclass restricted and retained immunoreactivity to A. actinomycetemcomitans antigens. Affinity-purified IgG2 antibodies were evaluated by an in vitro opsonophagocytic assay that employed neutrophils obtained from donors who were homozygous for the H131 allotype of Fc gamma receptor type IIa (CD32), which efficiently binds human IgG2 antibodies. Affinity-purified IgG2 antibodies from LJP serum but not from sera of periodontally healthy individuals promoted phagocytosis and killing of A. actinomycetemcomitans. The expression of IgG2-dependent opsonic activity required the presence of complement. Incubation of A. actinomycetemcomitans with neutrophils in the presence of an optimal concentration of LJP IgG2 (50 micrograms/ml) and 5% hypogammaglobulinemic serum (as a complement source) resulted in a > 1 log10 reduction in bacterial viability within 30 min. The opsonic activity of IgG2 antibodies was found to be comparable to that observed with affinity-purified IgG1 antibodies. Moreover, IgG1 antibodies interacted synergistically with IgG2 antibodies in promoting opsonophagocytosis of A. actinomycetemcomitans. The results of this study indicate that LJP serum contains IgG2 antibodies which, when employed in conjunction with neutrophils that express Fc gamma receptors capable of recognizing this subclass, are opsonic for A. actinomycetemcomitans.
机译:患有局部性少年牙周炎(LJP)的患者的血清通常含有水平升高的对放线放线杆菌的细胞包膜成分有反应性的免疫球蛋白G2(IgG2)抗体。这项研究的目的是确定这些IgG2抗体是否能够支持吞噬作用和人嗜中性粒细胞杀死放线放线杆菌的行为。通过亲和色谱法从高滴度LJP血清中制备多克隆IgG2抗体,得到的制剂受亚类限制> 99%,并保留了对A.放线杆菌的抗原的免疫反应性。通过体外调理吞噬试验评估亲和纯化的IgG2抗体,该试验采用从供体获得的嗜中性白细胞,这些供体与Fcγ受体IIa型H131同种型(CD32)纯合,可有效结合人IgG2抗体。从LJP血清中亲和纯化的IgG2抗体,但不是来自牙周健康个体血清的IgG2抗体,可促进吞噬作用和杀伤放线杆菌的作用。依赖IgG2的调理活性的表达需要补体的存在。在最佳浓度的LJP IgG2(50微克/毫升)和5%降血糖球蛋白血清(作为补体来源)存在下,放线杆菌与中性粒细胞一起孵育在30分钟内使细菌活力降低了> 1 log10发现IgG2抗体的调理活性与亲和纯化的IgG1抗体观察到的调理活性相当。此外,IgG1抗体与IgG2抗体协同相互作用,促进了放线放线杆菌的调理吞噬作用。这项研究的结果表明,LJP血清中含有IgG2抗体,当与表达能够识别该亚类的Fcγ受体的嗜中性粒细胞结合使用时,它对光放线放线杆菌有调理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号